Search
Protocol No.: COG-AALL1731
- Title
- A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)
- Principal Investigator
- Meyer, Ashley
- Phase
- III
- Age Group
- Both
- Applicable Disease Site
- Leukemia
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contacts
- Carla Corbin, RN, BSN
- Nurse Clinician
- Phone: +1 304-293-1217
- Email: ccorbin@hsc.wvu.edu
- April Shay, MSN, PNP-BC
- Nurse Practitioner
- Phone: +1 304-293-1217
- Email: ashay@hsc.wvu.edu
- Christy Glass, MSN
- APRN
- Phone: +1 304-598-4835
- Email: christy.glass@hsc.wvu.edu
- Ashley Kitzmiller, RN
- Nurse Coordinator
- Phone: +1 304-293-1217
- Email: ashley.tomasello@wvumedicine.org
- Sara Gamal, BS
- Coordinator National Quality Programs
- Phone: +1 304-974-5000
- Email: sara.gamal@wvumedicine.org